Coated-platelets correlate with disease progression in Alzheimer disease [10]

Journal of Neurology

Volumn 254, Issue 4, 2007, Pages 548-549

  Prodan, Calin I ^a,b   Ross, E D ^a,b   Vincent, A S ^c   Dale, G L ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; CHOLINESTERASE INHIBITOR; COLLAGEN; CONVULXIN; THROMBIN;

AGED; ALZHEIMER DISEASE; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; HUMAN CELL; LETTER; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; THROMBOCYTE ACTIVATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOOD PLATELETS; DISEASE PROGRESSION; HUMANS; MENTAL STATUS SCHEDULE;

EID: 34249082077     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0323-8     Document Type: Letter

References (14)

1. Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL (2000) Surface expression and functional characterization of alpha-granule factor V in human platelets: Effects of ionophore A23187, thrombin, collagen and convulxin. Blood 95:1694-1702
2. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders. Washington DC
3. Baskin F, Rosenberg RN, Iyer L, Hynan L, Cullum CM (2000) Platelet APP isoform ratios correlate with declining cognition in AD. Neurology 54:1907-1909
4. Colciaghi F, Borroni B, Pastorino L, Marcello E, Zimmermann M, Cattabeni F, Padovani A, Di Luca M (2002) [alpha]- Secretase ADAM10 as well as [alpha] APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med 8:67-74
5. Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, Clemetson KJ, Alberio L (2002) Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 415:175-179
6. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-19
7. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944
8. Padovani A, Pastorino L, Borroni B, Colciaghi F, Rozzini L, Monastero R, Perez J, Pettenati C, Mussi M, Parrinello G, Cottini E, Lenzi GL, Trabucchi M, Cattabeni F, Di Luca M (2001) Amyloid precursor protein in platelets - A peripheral marker for the diagnosis of sporadic AD. Neurology 57:2243-2248
9. Padovani A, Borroni B, Colciaghi F, Pettenati C,Cottini E, Agosti C, Lenzi GL, CaltagironeC, Trabucchi M, Cattabeni F, Di Luca M (2002)Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. Arch Neurol 59:71-75
10. Prodan CI, Szasz R, Vincent AS, Ross ED, Dale GL (2006) Coated-platelets retain amyloid precursor protein on their surface. Platelets 17:56-60
11. Rosenberg RN, Baskin F, Fosmire JA, Risser R, Adams P, Svetlik D, Honig LS, Cullum CM, Weiner MF (1997) Altered amyloid protein processing in platelets of patients with Alzheimer disease. Arch Neurol 54:139-144
12. Szasz R, Dale GL (2002) Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT-platelets. Blood 100:2827-2831
13. Szasz R, Dale GL (2003) COAT-platelets. Current Opinion Hematol 10:351-355
14. Tang K, Hynan LS, Baskin F, Rosenberg RN (2006) Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease. J Neurol Sci 240:53-58